Yu-Wen Cheng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Yi-Wei Kao, Tze Fan Chao, Shao-Wei Chen, Yu-Wen Cheng, Yi-Hsin Chan, Pao-Hsien Chu
Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level. Journal of the American Heart Association 13 (9) (2024)
Yi-Wei Kao, Tze Fan Chao, Shao-Wei Chen, Yu-Wen Cheng, Yi-Hsin Chan, Pao-Hsien Chu
Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level. Journal of the American Heart Association (2024)
Yi-Wei Kao, Tze Fan Chao, Shao-Wei Chen, Yu-Wen Cheng, Yi-Hsin Chan, Pao-Hsien Chu
Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level. Journal of the American Heart Association 13 (9) (2024)
Yi-Wei Kao, Tze Fan Chao, Shao-Wei Chen, Yu-Wen Cheng, Yi-Hsin Chan, Pao-Hsien Chu
Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level. Journal of the American Heart Association 13 (9) (2024)